$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What is the mechanism of action of tucatinib?
2026-02-01 22:25:32
Check Details
What is the difference between tucatinib and neratinib?
2026-02-01 22:25:32
Check Details
Introduction to the KRAS G12C mutated lung cancer targeted drug sotoraxib
2026-02-01 22:25:32
Check Details
An in-depth analysis of the efficacy and selection of generic drugs of sotoraxib
2026-02-01 22:25:32
Check Details
Comprehensive guidelines and precautions for the treatment of KRAS G12C mutated NSCLC with sotoracib
2026-02-01 22:25:32
Check Details
Which cancer types is osimertinib effective for? What are the indications?
2026-02-01 22:25:32
Check Details
How much will Osimertinib cost after medical insurance in 2024? Will generic drugs be cheaper?
2026-02-01 22:25:32
Check Details
How about the Laos generic version of tepotinib? What should I pay attention to when purchasing?
2026-02-01 22:25:32
Check Details
Which generation of targeted drug is Tepotinib? Which company developed it?
2026-02-01 22:25:32
Check Details
Latest related prices for venetoclax/venetoclax in 2024
2026-02-01 22:25:32
Check Details
Which country is venetoclax/venetoclax produced in?
2026-02-01 22:25:32
Check Details
Complete instructions for use of Venetoclax/Venetoclax
2026-02-01 22:25:32
Check Details
1
2
...
1185
1186
1187
1188
1189
1190
1191
...
10225
10226
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
2
Cemiplimab Storage and Handling Guide
3
ASCO 2026: Spevatamig Opens a New Path in Pancreatic Cancer Immunotherapy
4
FDA Approves First mRNA Flu Vaccine mFLUSIVA
5
Nintedanib Indications Explained: Beyond Idiopathic Pulmonary Fibrosis
6
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
7
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
8
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
9
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
10
Tazemetostat: Mechanism, Standard Dosing, and the 2026 Global Withdrawal of the First-in-Class EZH2 Inhibitor
11
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
12
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer